Abstract
The genomes of filamentous fungi comprise numerous putative gene clusters coding for the biosynthesis of chemically and structurally diverse secondary metabolites (SMs), which are rarely expressed under laboratory conditions. Previous approaches to activate these genes were based primarily on artificially targeting the cellular protein synthesis apparatus. Here, we applied an alternative approach of genetically impairing the protein degradation apparatus of the model fungus Aspergillus nidulans by deleting the conserved eukaryotic csnE/CSN5 deneddylase subunit of the COP9 signalosome. This defect in protein degradation results in the activation of a previously silenced gene cluster comprising a polyketide synthase gene producing the antibiotic 2,4-dihydroxy-3-methyl-6-(2-oxopropyl)benzaldehyde (DHMBA). The csnE/CSN5 gene is highly conserved in fungi, and therefore, the deletion is a feasible approach for the identification of new SMs.
INTRODUCTION
Since its discovery by Fleming in the 1920s, fungal penicillin has saved the lives of millions. Currently, the World Health Organization forecasts that the dramatic increase in antimicrobial resistance all over the world might lead to a disaster and proclaims a need for novel drugs (22). Certain fungi, plants, and bacteria produce various potent secondary metabolites (SMs) that span a wide field of structurally and chemically diverse natural products. With almost 1.5 million species (33), the fungal kingdom is a major reservoir for bioactive natural products as beneficial antibiotics and antitumor drugs but also as deleterious mycotoxins and food contaminants (28, 38). Although many fungal SMs have been described and tested, their complete potential is by far not exploited.
In recent years, different approaches were applied to find novel bioactive SMs either in new species or in already established model organisms. New geographical spots exhibiting extreme conditions were explored in order to find new species producing as-yet-unknown natural products (37). An alternative approach is the exploration of the full genomic potential of already known species by genomic mining (13, 14, 30, 76). Genomic sequencing revealed that there are many more genes for the biosynthesis of SMs than the metabolites already identified. These genes are often clustered, but most of them are rarely expressed under laboratory conditions (35), making the identification of their chemical products challenging. Two major strategies were applied to activate hidden genes: (i) changing the environment or (ii) genetic engineering (19, 35, 56). (i) The OSMAC (one strain, many compounds) approach activates silent gene clusters by cultivating microorganisms under different conditions (10, 75). Alternatively, physical contact with an opponent results in the uncovering of hidden clusters by activating defense mechanisms (58). (ii) Genetic engineering is focused primarily on expressing complete gene clusters in heterologous hosts (53, 77) or on altering the cellular transcription or protein synthesis machinery. Thus, SM synthesis was enhanced by changing genes with regulatory (12, 59), ribosomal (36, 49), protein-modifying (57, 64), or chromatin-modifying (11, 48, 61) functions or by adding epigenetic modifiers with DNA methyltransferase or histone deacetylase inhibiting function (26, 34, 70). A more selective approach is the artificial expression of a specific transcription factor (TF) gene embedded in a silenced gene cluster, which is able to activate SM synthesis (8, 20), or the direct expression of the biosynthetic genes by an inducible promoter (1).
Here, we describe the proof of principle of an alternative genetic approach to discover products of silent SM genes by impairing the control of the protein destruction machinery. Most nuclear and cytoplasmic proteins, including many TFs, are degraded by the proteasome pathway, which requires the ubiquitin labeling of target proteins. The activity of the multiprotein COP9 signalosome complex (CSN) plays a crucial role in controlling this process (71). In its fifth subunit, CSN5/CsnE, there resides a deneddylase catalytic activity, which detaches the ubiquitin-like protein Nedd8 from cullin-based ubiquitin E3 ligases. The covalent linkage of Nedd8 to a lysine residue of cullins activates E3 enzymes, which control ubiquitin-mediated protein degradation in the cell (15). The deletion of the gene for CSN5/CsnE, which is highly conserved in eukaryotes, results in embryonic death in plants or animals but results in viable fungal mutant strains altered in secondary metabolism and development (69). This suggests that regulators of secondary metabolism and development cannot be degraded properly, resulting in the false expression of SM genes. We used this approach in combination with a recently established technique targeting TFs (8, 20) to identify as-yet-undescribed SM clusters for the model ascomycete Aspergillus nidulans. Genomic sequencing predicted 32 polyketide synthases (PKSs), 27 nonribosomal peptide (NRP) synthases, and 6 dimethyl-allyl-tryptophan synthetases in A. nidulans (12, 58, 66), but only a few of them have been identified. The control of secondary metabolism and development is coordinated at the molecular level (5, 6, 74) and requires an intact CSN (15, 17, 18). The identification and deletion of the conserved CSN5/csnE genes might be accomplished even if an interesting fungal genome is not yet sequenced. Therefore, fungal CSN5/csnE mutant strains are an interesting reservoir for the discovery of novel SMs.
MATERIALS AND METHODS
Strains and growth conditions.
Strains used in this study are listed in Table S1 in the supplemental material. Aspergillus nidulans strains were grown on minimal medium (0.52 g/liter KCl, 0.52 g/liter MgSO4, 1.52 g/liter KH2PO4, 0.1% trace element solution [pH 6.5]) (4) at 30°C or 37°C and supplemented appropriately with 1 μg/ml pyridoxine-HCl, 1 μg/ml uracil, 0.25 μg/ml uridine, 1 μg/ml 4-aminobenzoic acid, 1 μg/ml pyrithiamine (TaKaRa Bio Inc., Münsing, Germany), 120 μg/ml nourseothricin-dihydrogen sulfate (clonNAT; Werner BioAgents, Jena, Germany), 80 μg/ml phleomycin (Cayla-InvivoGen, Toulouse, France), and 5 mg/plate DHMBA. d-Glucose (1%) served as the carbon source, and 10 mM nitrate or ammonium served as the nitrogen source. For solid medium, 2% agar was added. For the induction of sexual development, cultures were grown in the dark under oxygen limitation conditions, and for the induction of asexual development, cultures were grown in light (21). Escherichia coli strains DH5α and MACH-1 (Invitrogen GmbH, Karlsruhe, Germany) were used for the preparation of plasmid DNA and were cultivated in LB medium (1% tryptone, 0.5% yeast extract, 1% NaCl) supplemented with 100 μg/ml ampicillin or 50 μg/ml kanamycin. Bacterial strains for bioactivity tests were propagated on LB medium. Sordaria macrospora cells were grown on BMM medium (2.5% maize meal, 0.8% biomalt [pH 6.5]) (25). Verticillium longisporum cells were propagated on SXM medium (0.2% sodium pectin, 0.4% casein, 0.52 g/liter KCl, 0.52 g/liter MgSO4, 1.52 g/liter KH2PO4, 0.1% trace element solution [pH 6.5]), and Neurospora crassa cultures were grown on Vogel's minimal medium with 2% sucrose (65). For MIC tests, Micrococcus luteus cells were grown in Mueller-Hinton broth (Carl Roth, Karlsruhe, Germany).
Strain and plasmid constructions.
Strains and plasmids generated and used in this study are listed in Tables S1 and S2 in the supplemental material. For construction details, see the supplemental material.
Transformation procedures.
Transformation in A. nidulans was performed by the polyethylene glycol-mediated fusion of protoplasts, as described previously (24). Transformation in E. coli was performed with calcium/manganese-treated cells (32).
Analysis of secondary metabolites. (i) General experimental procedures.
1H nuclear magnetic resonance (NMR) spectra were recorded on Varian Mercury-Vx 300 (300 MHz) and Varian VNMRS-300 (300 MHz) spectrometers. 13C-NMR spectra were recorded on a Varian Inova-500 spectrometer (125.7 MHz). Electrospray ionization mass spectrometry (ESI-MS) data were acquired by using a Finnigan LC-Q mass spectrometer. High-performance liquid chromatography (HPLC) was performed by using a system from Instrumentelle Analytik Goebel GmbH (for analytical HPLC, HPLC pump 420, SA 360 autosampler, Celeno UV-DAD HPLC detector, ELSD-Sedex 85 evaporative light-scattering detector (ERC), Nucleodur 250-mm by 3-mm 100-5 C18 end-capped (ec) column, and a solvent system where solvent A was H2O plus 0.1% trifluoroacetic acid [TFA] and solvent B was acetonitrile plus 0.1% TFA; for preparative HPLC, Rainin Dynamax SD-1 HPLC pump, Rainin Dynamyx UV-1 HPLC detector, Nucleodur 250-mm by 20-mm 100-5 C18 ec column, and a solvent system where solvent A was H2O and solvent B was acetonitrile).
(ii) Cultivation.
One liter of liquid minimal medium with nitrate or ammonium as the nitrogen source was inoculated with 109 spores, and the culture was grown at 37°C for 36 h. For metabolic fingerprinting by ultraperformance liquid chromatography coupled with a time-of-flight mass spectrometer (UPLC–TOF-MS) (see Fig. 4D), cultures were grown for 10 days at 37°C in P flasks.
Fig 4.
Metabolic fingerprinting of the ΔcsnE and cluster mutants. (A) Phenotypes of TF dbaA and PKS dbaI gene deletions in wild-type and ΔcsnE backgrounds. ect., ectopically integrated. (B) Northern hybridization of the ΔdbaI/ΔcsnE deletion strain. Expression levels of gpdA and csnE were used as internal controls. (C) Clustering of the intensity profiles of 895 metabolite marker candidates of the ethyl acetate extraction phases of the wild-type, ΔcsnE, ΔdbaI, and ΔcsnE/ΔdbaI strains by 1D-SOM. The horizontal and vertical dimensions correspond to prototypes 1 to 10 and the analyzed fungus strains, respectively. Prototypes 6 and 7 (red frame) represent metabolite markers, which accumulate specifically in the ΔcsnE strain. Colors of matrix elements represent average intensity values. For the complete data set, see Table S7 in the supplemental material. (D) Box-whisker plots showing the relative abundances of DHMBA, which was detected in prototype 6, and of orsellinic acid, which was detected in prototype 8. (E) Western blot of the C-terminally TAP-tagged TF DbaA. Ponceau staining is shown as an equal loading control.
(iii) Extraction.
Mycelia of cultures were removed by filtering with Miracloth, and the pH of the culture filtrate was adjusted to 5. The culture filtrate was extracted twice with an equivalent amount of ethyl acetate. The combined extracts were dried to yield the crude extract.
(iv) Analysis by HPLC coupled with a UV diode array detector (UV-DAD).
The crude extracts were dissolved in 2 ml methanol (MeOH) and analyzed by HPLC using an analytical column under gradient conditions (20% solvent B to 100% solvent B in 20 min).
(v) Isolation of DHMBA.
After ethyl acetate extraction, the crude extract of 2-liter cultures of strain AGB527 (grown in inducing medium) was extracted with CH2Cl2. The resulting extract was concentrated and chromatographed by preparative HPLC under gradient conditions (20% solvent B to 100% solvent B in 20 min, at a flow rate of 14 ml/min). Detection was carried out at 230 nm. DHMBA (3.9 mg) was eluted at 14.4 min. For detailed chemical data, see the supplemental material.
(vi) Isolation of DHPDI.
The crude extract of 7-liter cultures of strain TNO (grown in inducing medium) was extracted with CH2Cl2. The resulting extract was concentrated and fractionated by preparative HPLC under gradient conditions (20% solvent B to 100% solvent B in 20 min, at a flow rate of 14 ml/min). Detection was carried out at 230 nm. The fraction which eluted at 12.0 min was further chromatographed on a Sephadex column by using MeOH as the solvent and yielded 1.4 mg of the compound 3,3-(2,3-dihydroxypropyl)diindole (DHPDI). For detailed chemical data, see the supplemental material.
Bioactivity tests.
The potential antibiotic or antifungal activities of the isolated metabolites DHMBA and DHPDI were tested by agar diffusion tests. Twenty-five microliters of a methanolic solution of the substances (c = 1 mg/ml) was added onto sterile filter discs (diameter, 9 mm) and put onto agar plates inoculated with Escherichia coli, Bacillus subtilis, Micrococcus luteus, Staphylococcus aureus, Salmonella enterica serovar Typhimurium, Agrobacterium tumefaciens, Pseudomonas fluorescens, Streptomyces griseus, Aspergillus fumigatus, Aspergillus nidulans, Verticillium longisporum, Neurospora crassa, and Sordaria macrospora. Inhibition zones were measured after 1 to 5 days at 37°C or 25°C, respectively.
The MIC was determined by a microplate assay (44). M. luteus cells were grown overnight in Mueller-Hinton broth, and the optical density (OD) was adjusted to 0.1. Twofold dilutions of DHMBA (2 mg/ml) and the reference antibiotic vancomycin (2 mg/ml) were prepared with the microtiter plates. Finally, the wells contained 100 μl of Mueller-Hinton broth with or without an inhibitor as a control. Twenty-five microliters of the bacterial suspension was added, and the plates were cultivated for up to 24 h at 30°C. The OD was measured at 630 nm with a microplate reader (InfiniTe M2000 [Monochromator]; Tecan, Crailsheim, Germany). Mueller-Hinton broth was used as a blank incubated under the same conditions. The MIC was calculated from the highest antibiotic dilution showing complete inhibition. The tests were performed independently in triplicate.
Metabolic fingerprinting by UPLC–TOF-MS.
Two biological replicates of each sample were analyzed three times by UPLC (Acquity UPLC system; Waters Corporation) coupled with a photodiode array (PDA) detector (UPLC eLambda, 800 nm; Waters Corporation) and with an orthogonal time-of-flight mass spectrometer (LCT Premier; Waters Corporation) (see the supplemental material for detailed information).
Identification of a putative binding site for DbaA.
For motif predictions, the intergenic regions of the genes dbaA, dbaB/dbaC, dbaD/dbaE, dbaF/dbaG, and dbaH/dbaI were submitted to the MEME tool (2). Only one motif was found for all five sequences with a P value of 10−6 to 10−7 (see Table S3 in the supplemental material). This motif was next submitted to the TOMTOM tool (31) for the identification of similarities to known TF binding sites. The motif showed significant similarities to the yeast Zn(II)2-Cys6 TFs RGT1 (P = 10−3) and ECM22 (P = 10−2). To check the specificity of the motif found for the cluster sequences, the FIMO tool (29) was run on the set of 25 sequences (5 cluster promoters plus 10 promoters up- and downstream of the cluster) (see Table S4 in the supplemental material). With a P value of 10−6, all cluster-specific sites were recovered, whereas only one additional site (in the intergenic region between AN7893 and AN7894) was detected in the flanking promoters.
RESULTS
The A. nidulans ΔcsnE mutant activates a silent biosynthetic gene cluster comprising a PKS gene.
The A. nidulans ΔcsnE mutant is deficient in the enzyme activity of COP9, which is involved in protein turnover control (45). The mutant is sensitive to oxidative stress (45) and accumulates pigments, which are absent in the wild type (Fig. 1A). Recently, we identified several of the pigments as orcinol and related phenylethers (45). Some of them were also found during an analysis of the recently identified orsellinic acid gene cluster comprising orsA to orsE (AN7909 to AN7914, respectively) (54).
Fig 1.

Deletion of the csnE subunit activates a novel putative biosynthetic gene cluster normally silenced in the wild type. (A) Phenotype of the wild-type (wt) and ΔcsnE strains after 3 days of asexual growth at 37°C. Pictures were taken from the top and the bottom of agar plates. The ΔcsnE mutant accumulates pigments around colony margins. (B) Transcriptional expression of genes in the ΔcsnE mutant compared to the wild type at different developmental stages (V, vegetative; A, asexual; S, sexual; 14, 14 h; 20, 20 h; 48, 48 h). Genes with log2 ratios of ≥3.2 and adjusted P values of ≤0.01 were regarded as being significantly regulated, and genes with log2 ratios of ≥2 and adjusted P values of ≤0.01 were regarded as being moderately regulated. ↑, significantly upregulated; ↗, moderately upregulated; ↘, moderately downregulated; 0, not regulated. (C) Northern hybridization of three genes of the putative gene cluster. Samples were taken after 20, 24, and 48 h of asexual growth (A20, A24, and A48, respectively) and after 24 and 48 h of sexual growth (S24 and S48, respectively). Expression levels of gpdA and rRNA were used as internal controls. The expression levels of AN7893, dbaA, and dbaI were upregulated in the ΔcsnE mutant compared to the wild type.
We analyzed the protein-degradation-impaired A. nidulans ΔcsnE mutant for its secondary metabolism by a genome-wide transcriptional profiling of ΔcsnE mutant cells during development (45). Besides genes involved in sterigmatocystin (ST) (45) and orsellinic acid biosynthesis (see Table S5 in the supplemental material), the analysis revealed that an uncharacterized putative cluster containing a nonreducing PKS gene was upregulated in the ΔcsnE strain but silenced in the wild type (AN7893 to AN7903) (Fig. 1B). The direct PKS product was recently identified as 2,4-dihydroxy-3-methyl-6-(2-oxopropyl)benzaldehyde (DHMBA) (1). The cluster genes were upregulated in comparison to the wild type in at least one developmental stage. We designated the genes of the putative cluster dbaA to dbaI (derivative of benzaldehyde), referring to the identified PKS gene product. The putative cluster spans 12 genes in total (Table 1). The cluster contains two putative TF-encoding genes, dbaA, with a Zn(II)2-Cys6 domain, and dbaG, encoding a protein with significant similarities to other putative fungal TFs (Aspergillus fumigatus [NCBI accession number XP_746385, 41% identities]). The initial microarray data were confirmed by Northern analysis of 3 randomly selected genes (AN7893, dbaA, and dbaI) of the new putative PKS gene cluster (Fig. 1C), suggesting that CSN is involved in the repression of this gene cluster in wild-type A. nidulans cells.
Table 1.
Encoded proteins of the dba gene cluster and their proposed functionsa
| Protein | Locus tag | Proposed function | Predicted length (aa) | 
|---|---|---|---|
| DbaA | AN7896 | Zn(II)2-Cys6 transcription factor | 595 | 
| DbaB | AN7897 | FAD-binding monooxygenase | 393 | 
| DbaC | AN11584 | Protein with YCII domain | 109 | 
| DbaD | AN7898 | General substrate transporter (MFS) | 456 | 
| DbaE | AN7899 | Esterase/lipase | 278 | 
| DbaF | AN7900 | FAD-dependent oxidoreductase | 476 | 
| DbaG | AN7901 | Putative fungal transcription factor (no conserved domain) | 421 | 
| DbaH | AN7902 | FAD binding monooxygenase | 462 | 
| DbaI | AN7903 | Nonreducing polyketide synthase | 2,605 | 
aa, amino acids; FAD, flavin adenine dinucleotide.
Northern hybridization determines the borders of the dba gene cluster.
Numerous gene clusters carry a specific transcriptional activator (TF) gene which is embedded within the cluster (8, 20). To determine the boundaries of the novel gene cluster and to discriminate the effect on secondary metabolism, we designed strains overexpressing the putative TF-encoding gene dbaA or dbaG, respectively, under the control of the inducible nitrate reductase gene promoter (see Fig. S1 in the supplemental material). The overexpression of dbaG led to no significant changes in phenotype, whereas the overexpression of dbaA caused a strong extracellular pigmentation and a reduced growth diameter of the colony (Fig. 2A). Interestingly, the pigmentation depends on pH and is reversible: in neutral and basic milieus, the culture filtrate was yellow, while at a pH of <3, it turned colorless (Fig. 2B).
Fig 2.
Boundaries of the dba gene cluster. (A) Phenotypes of dbaA- and dbaG-overexpressing strains. All strains were grown in inducing nitrate (NO3−) and repressing ammonium (NH4+) media. (B) Reversible pH dependency of yellow metabolites produced in the dbaA-OE strain grown in inducing nitrate medium for 24 h. (C) Northern hybridization of the genes AN7893 to orsA (AN7909) defines boundaries of the dba gene cluster. Strains were grown in inducing nitrate (+) and repressing ammonium (−) media. The expression level of gpdA was used as an internal control. The genes upregulated in both Northern and microarray analyses (Fig. 1B) were designated dbaA to dbaI. (D) Scheme of the dba gene cluster. The gene cluster contains the TF gene dbaA (AN7896); the oxygenase genes dbaB (AN7897), dbaF (AN7900), and dbaH (AN7902); the YCII domain gene dbaC (AN11584); the transporter gene dbaD (AN7898); the esterase/lipase gene dbaE (AN7899); the TF gene dbaG (AN7901); and the PKS gene dbaI (AN7903) (Table 1).
We performed Northern hybridization experiments with the dbaA-overexpressing (OE) and dbaG-OE strains (Fig. 2C). All genes starting from AN7893 to AN7909 (orsA) were used as probes, where we compared the promoter-repressing and -inducing conditions for the corresponding TF. The dbaG-overexpressing strain exhibited increased expression of the putative oxidoreductase gene dbaF only, whereas the expression levels of the AN7893, dbaA, dbaC, and dbaD genes even decreased.
In contrast, the overexpression of dbaA coordinately upregulated all consecutive genes from the AN7897 (dbaB) gene to the PKS-encoding AN7903 (dbaI) gene (Fig. 2C), indicating that these genes form a cluster which is controlled by the fungal Zn(II)2-Cys6 TF DbaA, encoded by the most 5′-upstream-located gene (AN7896) (Fig. 2D). DbaA also controls the second putative TF gene, dbaG (AN7901), suggesting a complex transcriptional control of the entire dba gene cluster.
By comparisons of the intergenic regions of the dba cluster (AN7896 and the intergenic regions between AN7897 and AN11584, AN7898 and AN7899, AN7900 and AN7901, and AN7902 and AN7903), a motif shared by all five sequences was found which is not present in the intergenic regions of the neighboring genes except for the intergenic region of AN7893/7894. A regulation for AN7893 (encoding a putative oxygenase) and AN7894 (encoding a putative YCII-related domain) was also detected in the transcriptome data (see Table S5 in the supplemental material) but not by Northern hybridization (Fig. 2C). The shared motif (CT/CCG/AGA/CG/CT/A/CA/TT/A/GC) shows significant similarities to the binding sites of the yeast Zn(II)2-Cys6 TFs RGT1 (Ykl038w) and ECM22 (YLR228C), corroborating our findings.
DHMBA and DHPDI are mutually exclusive metabolites.
In order to identify the SMs produced by the dba gene cluster, wild-type and dbaA-OE strains were compared after cultivation in promoter-inducing medium. Culture filtrates were extracted with ethyl acetate and subsequently analyzed by high-performance liquid chromatography coupled with a UV diode array detector (HPLC–UV-DAD). The analysis revealed a major peak at the 10.3-min retention time with absorption maxima at 221 and 296 nm for the dbaA-OE strain and a peak at a 10.6-min retention time with absorption maxima at 231 and 276 nm for the wild-type strain (Fig. 3A). Interestingly, both peaks were mutually exclusive. We determined the structures of the two compounds by nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry after cultivating both strains in larger amounts and applying different chromatographic methods for metabolite isolation (see Fig. S2A and S2B in the supplemental material).
Fig 3.

Identification of metabolites. (A) HPLC–UV-DAD chromatogram of the wild-type (magenta) and dbaA-OE (cyan) strains. abs., absorbance. (B) Chemical structures of 2,4-dihydroxy-3-methyl-6-(2-oxopropyl)benzaldehyde (DHMBA) and 3,3-(2,3-dihydroxypropyl)diindole (DHPDI). (C) Agar diffusion tests of DHMBA and DHPDI. Agar plates were inoculated with Micrococcus luteus cells and grown for 24 h at 37°C. Twenty-five microliters of DHMBA and DHPDI (1 mg/μl) was spotted onto filter discs. The inhibition zone of DHMBA was 2.5 cm.
The compound isolated from the dbaA-OE strain was identified as DHMBA (Fig. 3B), which was recently identified as a direct PKS product of DbaI (1). Interestingly, the UV spectrum of DHMBA was pH dependent. In the acidic milieu, the UV maxima were 221 and 296 nm, while with increasing pHs, the UV maxima shifted to higher values, 225, 295, and 340 nm in the neutral milieu and 257 and 341 nm in the basic milieu.
The compound isolated from the wild type was identified as the alkaloid 3,3-(2,3-dihydroxypropyl)diindole (DHPDI), which has not been described previously for aspergilli (Fig. 3B). Interestingly, the occurrence of DHPDI was medium dependent. After cultivation in nitrate medium, DHPDI was present, while in ammonium medium, the culture lacked DHPDI (see Fig. S2C in the supplemental material).
Besides the major peak, several minor peaks were present in the dbaA-overexpressing strain in the HPLC–UV-DAD chromatogram (retention times between 5 and 9 min) (Fig. 3A). Some of these peaks showed UV-visible (UV-Vis) maxima above 350 nm, indicating that these yellow components might contribute to the yellow color of the culture filtrate. Analysis by UPLC–TOF-MS revealed the exact masses of 21 compounds, which were produced in larger amounts in the dbaA-OE strain than in the wild type, 7 of which had UV maxima above 350 nm (see Table S6 in the supplemental material), indicating a yellow color.
DHMBA exhibits antibiotic activity in agar diffusion tests.
We analyzed the putative antibiotic activities of DHMBA and DHPDI. In an initial screening, antibacterial and antifungal activities were tested by agar diffusion tests with different Gram-positive and Gram-negative bacteria as well as filamentous fungi (for a complete list, see Materials and Methods). The tests revealed no antibiotic activity for DHPDI. In contrast, DHMBA showed specific antibacterial activity against the Gram-positive bacterium Micrococcus luteus, with an inhibition zone of 2.5 cm in diameter after 24 h of growth (Fig. 3C). Thus, we determined the MIC of DHMBA against M. luteus in a microplate assay. The MIC was 3.1 μg/ml. This DHMBA-mediated antibacterial activity, which might contribute to the survival of the fungus, supports our approach of using csnE mutant strains for exploring the secondary metabolism potential for bioactive compounds of filamentous fungi.
Deletion of the PKS gene dbaI in the ΔcsnE mutant results in the loss of numerous metabolite marker candidates, including DHMBA.
For a comprehensive metabolite analysis of the dba gene cluster, we deleted the PKS-encoding gene dbaI in the wild-type and ΔcsnE backgrounds (Fig. 4A; see also Fig. S3 in the supplemental material). The lack of pks transcripts was verified by Northern hybridization (Fig. 4B). As expected, due to the silencing of the cluster, the deletion of dbaI in the wild type caused no phenotypic changes, but in the ΔcsnE mutant, the deletion resulted in an alteration of the ΔcsnE-specific pigments surrounding the colony margin (Fig. 4A). The introduction of the csnE genomic fragment restored the wild-type and dbaI deletion phenotypes (not shown), and the ectopic introduction of the dbaI gene fused to the gpdA promoter restored the csnE deletion phenotype (Fig. 4A).
The metabolite production of the A. nidulans strain deficient in the COP9 signalosome was analyzed by a metabolite fingerprinting analysis. Extracellular ethyl acetate extracts of the wild-type, ΔcsnE, ΔdbaI, and ΔdbaI/ΔcsnE strains were analyzed by UPLC–TOF-MS. The intensity profiles of 895 marker candidates (P < 1 × 10−6) of the positive and negative ionization modes were clustered by training a one-dimensional self-organizing map (1D-SOM) model (42) and were grouped into 10 prototypes (Fig. 4C; see also Table S7 in the supplemental material). Prototypes 6 and 7 represent 184 marker candidates that were upregulated in the ΔcsnE mutant but only when the PKS DbaI was present. Among them, DHMBA was detected in prototype 6 (Fig. 4D). Its production was enhanced in the ΔcsnE mutant compared to wild-type levels but ceased when dbaI was deleted. Furthermore, the recently identified orsellinic acid (58) was detected in prototype 8 (Fig. 4D). As our microarray results suggested, its production was augmented in the ΔcsnE mutant compared to the wild type. In the ΔdbaI/ΔcsnE strain, orsellinic acid production was diminished but not ceased, indicating cross talk between the two PKSs DbaI and OrsA, as was suggested previously (46, 58).
Furthermore, we analyzed the influence of the TF DbaA on dba gene cluster expression in the ΔcsnE mutant. Therefore, a dbaA deletion strain was constructed in the wild-type and ΔcsnE backgrounds (see Fig. S3 in the supplemental material). Like the pks deletion, no phenotypic changes were observed in the wild-type background, while in the ΔcsnE background, again, a change of pigments was observed (Fig. 4A). For the ΔdbaA/ΔcsnE mutant, the deletion phenotype was restored by the ectopic integration of a dbaA genomic fragment.
We tested whether the deletion of csnE increases the amount of the TF DbaA. Therefore, we designed a ctap (tandem affinity purification [TAP])-tagged dbaA construct and expressed it in the wild-type and ΔcsnE backgrounds (see Fig. S3 in the supplemental material). A Western blot experiment with the anti-calmodulin binding peptide antibody, recognizing the calmodulin binding peptide (CBP) of the TAP tag, showed strong production of DbaA in the ΔcsnE background but not in the wild-type background (Fig. 4E). Our results suggest that protein levels of the TF DbaA accumulate in the absence of CsnE.
The oxygenase DbaH is required for yellow pigment production and is involved in sexual development.
We designed deletion mutants of all dba genes in the dbaA-OE and wild-type backgrounds in order to deepen our understanding of the new gene cluster and its possible function (see Fig. S4 in the supplemental material). Phenotypes of all deletions are summarized in Fig. 5A. In the wild-type background, all deletions exhibited no obvious phenotype, presumably due to the silencing of the gene cluster. In the dbaA-OE background, the ΔdbaB, ΔdbaC, ΔdbaE, and ΔdbaF strains showed no phenotypic changes compared to the dbaA-OE strain. However, the ΔdbaD, ΔdbaG, and ΔdbaH strains largely lost the ability to produce yellow pigments. For the ΔdbaD and ΔdbaG strains, pigment production was observed only weakly in liquid but not on solid medium, and the ΔdbaH strain completely lost the yellow color and instead produced red pigments (see Fig. S5 in the supplemental material). Interestingly, all yellow strains had a reduced growth diameter, whereas the strains without yellow pigments had a growth diameter similar to that of the wild type (Fig. 5B), suggesting a toxic effect of secreted metabolites.
Fig 5.
Phenotypes of dba cluster deletions in the wild-type and dbaA-OE backgrounds. (A) Growth test on inducing nitrate (NO3−) and repressing ammonium (NH4+) media. For asexual development, strains were grown for 3 days at 37°C in light. For the vegetative stage, strains were grown 24 h in liquid medium. (B) Growth diameters of cluster deletion colonies compared to the wild-type and dbaA-OE strains. The wild-type diameter was set to 100%. Strains were grown for 3 days in light on inducing nitrate medium. Green, no production of yellow metabolites; yellow, production of yellow metabolites. (C) Phenotypes for sexual development of the ΔdbaH/dbaA-OE, ΔdbaH, and wild-type strains. Strains were grown for 7 days at 37°C in the dark under conditions of limited oxygen levels. The ΔdbaH/dbaA-OE strain produces only a few cleistothecia with delayed pigmentation.
In addition, we analyzed the DHMBA production of the cluster deletion strains in the dbaA-OE background by HPLC analysis. All strains still produced DHMBA but in different amounts. While the ΔdbaE, ΔdbaF, and ΔdbaG strains produced reduced DHMBA amounts, the production in the ΔdbaH strain was enriched (Fig. 6). As DbaD contains the major facilitator superfamily (MFS) transporter domain, we conclude that it might be involved in the transport of the metabolites to the environment. dbaH encodes a putative oxygenase, and due to the loss of yellow pigments and the accumulation of DHMBA in the deletion strain, we conclude that DbaH is responsible for the synthesis of yellow pigments derived from the oxidation of DHMBA. The block of this reaction by the deletion of dbaH led to the accumulation of the putative precursor DHMBA. In addition to metabolic changes, the developmental phenotype was altered in the ΔdbaH/dbaA-OE strain. The strain was impaired in sexual development and produced very few colorless but fertile sexual fruit bodies (cleistothecia) after 7 days of sexual growth (Fig. 5C). At this stage, cleistothecium formation in the wild-type strain was completed. The production of Hülle cells, which are nursing cells to support fruit body development (55), was not affected. The few cleistothecia gained color after 10 days of growth. However, the exogenous addition of purified DHMBA to the growth medium of the ΔdbaH strain resulted in no change in sexual development.
Fig 6.

HPLC–UV-DAD chromatograms of cluster deletion strains in the dbaA-OE background. DHMBA is produced by all strains. In the ΔdbaD, ΔdbaE, and ΔdbaF strains, the level of DHMBA production was reduced, while in the ΔdbaH strain, production was enriched.
Our results suggest that the dba gene cluster has impacts not only on secondary metabolism but also on the developmental processes of the fungus.
DISCUSSION
The identification of silent and orphan gene clusters is of broad interest for biotechnology, including the pharmaceutical or food industry (9, 16, 27, 38). Only a fraction of all presumed biosynthetic genes and their products are known, and it is necessary to develop new tools for the activation of silent gene clusters. We showed here the successful application of a new approach to awaken silenced biosynthetic gene clusters. This approach is based on the idea that the interruption of the protein degradation machinery can lead to the increased stabilization of regulators, including transcriptional activators for biosynthetic gene clusters. We chose the deletion of the csnE gene, encoding a subunit of COP9 (CSN), where we had observed metabolic changes in previous studies (17, 45). The multiprotein complex CSN is highly conserved in eukaryotes (68) and plays a crucial role in the control of ubiquitin-mediated protein degradation in the cell (15). The csnE deletion mutant of A. nidulans is impaired in sexual reproduction (15, 45) and produces the bioactive benzaldehyde DHMBA (Fig. 3B).
Previously established strategies to activate silent gene clusters can affect single or multiple pathways of an organism, depending on their respective targets. As all strategies have their advantages and disadvantages, it is necessary to select the appropriate approach for the respective issue. The environmental OSMAC approach or the “interspecies cross talk” approach can activate many different silenced gene clusters in an organism (10, 58, 75). However, it can be tedious and difficult to determine the specific growth conditions from a variety of parameters and organisms. The heterologous expression of a complete gene cluster in a different host organism attacks single pathways (53), but PKS- and NRPS-encoding gene clusters are especially very large, making this strategy challenging. The expression of TF-encoding genes located within a cluster by inducible promoters is another successful strategy (8, 20) but might require many gene clusters to be tested in a fungus. Unfortunately, gene clusters can also contain more than one or even lack TF-encoding genes. With our approach, we attacked the protein degradation machinery. In recent studies, only protein synthesis has been targeted by ribosome engineering (36, 49) or by targeting protein modifiers (57, 64). Our CSN5-based approach activates multiple biosynthetic gene clusters in an organism for the rapid identification of SMs. The advantages are that no deeper knowledge of possibly present gene clusters is necessary and that the amount of TFs in the cluster is primarily nonrelevant, although this method (8, 20) can be combined with our approach at a later stage of the analysis.
Transcriptional profiling of the A. nidulans csnE deletion strain showed previously that many designated secondary metabolism genes were misregulated (45). Besides the newly identified dba gene cluster controlled by the TF DbaA, the recently identified orsellinic acid gene cluster comprised of orsA to orsE (58) was also partially upregulated in the ΔcsnE mutant (see Table S5 in the supplemental material), which was verified by 1D-SOM data showing orsellinic acid assigned to prototype 8 (Fig. 4D). Interestingly, the dba cluster is located directly 5′ upstream of the orsellinic acid gene cluster, and parts of the dba cluster were also upregulated during an orsellinic acid study reported previously by Nielsen et al. and Schroeckh et al. (46, 58). A cooperation of the PKSs DbaI and OrsA was hypothesized previously by Nielsen et al. (46). Those researchers showed that both PKS deletions led to a loss of F9775-A and F9775-B production, although both compounds could not be detected during our work.
The deduced amino acid sequences of the proteins encoded by the dba gene cluster (plus AN7893 to AN7895) were analyzed in silico in more detail. A BLAST (NCBI) search revealed that the amino acid sequences showed similarities to proteins of the citrinin-producing cluster of the mold Monascus purpureus and the methylorcinaldehyde-producing cluster of the mold Acremonium strictum (protein identities are given in Table S8 in the supplemental material). The structures of the tetraketide methylorcinaldehyde and DHMBA differ only in the ligand at the 3′ position of the phenol ring.
DHMBA was first isolated as a side product from the New Zealand fungus Sepedonium chrysospermum in 2006 (43) and was recently discovered in Aspergillus nidulans (1). Until 2006, it was known only as an intermediate in the chemical synthesis of azaphilones (63). Azaphilones are pigments with pyrone-quinone structures containing a highly oxygenated bicyclic core and quaternary center, like the yellow citrinin. Some of them show biological activities such as antimicrobial and antitumor activities (23, 50, 51, 73), and recently, the application of azaphilones as future food colorants was proposed (41). Several azaphilones have been identified from different fungal species, like Monascus, Penicillium, Epicoccum, and also Aspergillus species (20, 40, 60, 62), and recently, the first studies delivered insight into the biosynthetic pathway (20, 40). During the biosynthesis of asperfuranone, the first enzyme-free intermediate was identified as a benzaldehyde similar to DHMBA but differently substituted at the 6′ position (20). However, a hydroxylase-encoding gene is missing in the dba cluster to convert DHMBA to an azaphilone related to asperfuranone.
During feeding studies, 2,4-dihydroxy-3,5-dimethyl-6-(2-oxo-3-methylpropyl)benzaldehyde, a compound similar to DHMBA with two additional methyl groups, was identified as the first enzyme-free intermediate in the biosynthesis of citrinin (3). In accordance with this, we suggest that the PKS product DHMBA might also be an intermediate in the synthesis of an azaphilone related to citrinin. Osmanova et al. and Yang et al. even isolated metabolites from Aspergillus sp. synthesized from azaphilones and orsellinic acid (50, 72). Perhaps, the neighboring dba and ors clusters work together to synthesize metabolites related to those identified previously by Yang et al. (72), as both gene clusters are activated in the ΔcsnE mutant.
The conversion of DHMBA to the yellow pigments found in the ΔcsnE mutant or when dbaA is overexpressed might happen by the oxidation of DHMBA by the oxygenase DbaH, whose deletion results in the accumulation of DHMBA and a loss of yellow pigments. Interestingly, the deletion of the oxygenase-encoding gene dbaH in the dbaA-OE background also led to impaired sexual development. The very few cleistothecia that were found were delayed in pigmentation. However, the exogenous addition of DHMBA to the growth medium of the ΔdbaH mutant had no influence on sexual behavior, showing that not the accumulated DHMBA but other pleiotropic effects might trigger the defects in sexual development. Nevertheless, we cannot exclude problems in the uptake of exogenous DHMBA of the cells. A correlation between PKS gene cluster expression and sexual development was recognized previously for Neurospora crassa and Sordaria macrospora (47). The deletion mutant of the oxygenase-encoding gene fbm1, which is member of a PKS gene cluster in both organisms, also showed the formation of fewer and delayed fruit bodies. Although the dbaH and fbm1 sequences show no similarities, they might play a similar role in their organisms.
The follow-up experiments of our comparison of the dbaA-OE mutant and the wild type resulted in a second compound isolated from wild-type A. nidulans, which was 3,3-(2,3-dihydroxypropyl)diindole (DHPDI). This indole alkaloid was first found in mutants of Saccharomyces cerevisiae, which were blocked in tryptophan biosynthesis and accumulated different indole derivatives (39). Additionally, the toxic compound was isolated from the ergot-type symptom-causing fungus Balansia epichloë (52) and from the North Sea alphaproteobacterium Oceanibulbus indolifex (67), but to our knowledge, this is the first report of its isolation from aspergilli. Interestingly, the stability of DHPDI was pH dependent. While the diindole was stable in a basic milieu, at a pH of <3 it was converted into 2-oxo-3-indolyl-(3)-propan-1-ol, indole, and unknown indole polymers (39), which presumably explains the lack of DHPDI in ammonium-containing medium (see Fig. S2C in the supplemental material). After cultivation in ammonium medium, the pH of the cultures was around 2.4, while cultivation in nitrate medium resulted in a pH of 6.3.
Interestingly, the nitrogen-containing DHPDI, probably built up from tryptophan by a cryptic NRPS, is not produced anymore when dbaA is overexpressed. This might be due to pleiotropic effects but could also mean that there is an additional role of DbaA as a regulator for more than only one gene cluster. A recently reported study showed that TFs do not exclusively regulate the gene cluster in which they are embedded but that they are also able to navigate the cross talk between gene clusters located even on different chromosomes (7). Here, DbaA might additionally regulate the expression of the DHPDI-producing gene cluster. This could be a natural cross talk but also due to the misexpression of biosynthetic genes. Additionally, we identified the masses of 21 metabolites in the dbaA-OE strain, among them 3 nitrogen-containing compounds, which emphasizes our hypothesis of intercluster cross talk (see Table S6 in the supplemental material). In the ΔcsnE strain, we observed a reduced level of production of the aflatoxin precursor sterigmatocystin (ST) (45), whereas the overexpression of dbaA did not affect ST production (Fig. S6), implying an independence of dbaA from the well-studied ST gene cluster.
Despite recent progress in the development of different strategies, the identification of silent SM-producing gene clusters still remains challenging. Our new approach based on interrupting the protein degradation system gives a new possibility to uncover hidden SMs in a broader manner. We showed for the model A. nidulans, as a paradigm of an SM-producing filamentous fungus, that the deletion of CSN5/csnE results in the activation of several clusters. We detected the PKS products DHMBA and orsellinic acid in the mutant, and additionally, we identified the new metabolite DHPDI from the wild type, which was so far not known to be produced by aspergilli. It will be interesting in the future to see what other SMs can be identified by further csn mutants from other fungi or even lower plants like algae, which also promise to have a high potential for bioactive molecules, which are urgently required to combat multidrug-resistant microbes.
Supplementary Material
ACKNOWLEDGMENTS
We thank BioViotica Naturstoffe GmbH for providing equipment for the isolation and identification of secondary metabolites. We appreciate the experimental support of K. Nahlik in the initial phase of the project and of P. Meyer and A. Kaever. We thank M. Hoppert, S. Pöggeler, P. Neumann-Staubitz, S. Seiler, and R. Daniel for providing strains for bioactivity tests. We thank B. Joehnk for proofreading the manuscript.
This work has been funded by grants from the Deutsche Forschungsgemeinschaft (DFG), the Volkswagen-Stiftung, and the Fonds der Chemischen Industrie to G.H.B.
Footnotes
Published ahead of print 21 September 2012
Supplemental material for this article may be found at http://aem.asm.org/.
REFERENCES
- 1. Ahuja M, et al. 2012. Illuminating the diversity of aromatic polyketide synthases in Aspergillus nidulans. J. Am. Chem. Soc. 134:8212–8221 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 2. Bailey TL, Elkan C. 1994. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 2:28–36 [PubMed] [Google Scholar]
 - 3. Barber J, Carter RH, Garson MJ, Staunton J. 1981. The biosynthesis of citrinin by Penicillium citrinum. J. Chem. Soc. Perkin Trans. 1 1981:2577–2583 [Google Scholar]
 - 4. Barratt RW, Johnson GB, Ogata WN. 1965. Wild-type and mutant stocks of Aspergillus nidulans. Genetics 52:233–246 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 5. Bayram O, et al. 2012. The Aspergillus nidulans MAPK module AnSte11-Ste50-Ste7-Fus3 controls development and secondary metabolism. PLoS Genet. 8:e1002816 doi:10.1371/journal.pgen.1002816 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 6. Bayram O, et al. 2008. VelB/VeA/LaeA complex coordinates light signal with fungal development and secondary metabolism. Science 320:1504–1506 [DOI] [PubMed] [Google Scholar]
 - 7. Bergmann S, et al. 2010. Activation of a silent fungal polyketide biosynthesis pathway through regulatory cross talk with a cryptic nonribosomal peptide synthetase gene cluster. Appl. Environ. Microbiol. 76:8143–8149 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 8. Bergmann S, et al. 2007. Genomics-driven discovery of PKS-NRPS hybrid metabolites from Aspergillus nidulans. Nat. Chem. Biol. 3:213–217 [DOI] [PubMed] [Google Scholar]
 - 9. Blanc PJ, et al. 1995. Characterization of monascidin A from Monascus as citrinin. Int. J. Food Microbiol. 27:201–213 [DOI] [PubMed] [Google Scholar]
 - 10. Bode HB, Bethe B, Hofs R, Zeeck A. 2002. Big effects from small changes: possible ways to explore nature's chemical diversity. Chembiochem 3:619–627 [DOI] [PubMed] [Google Scholar]
 - 11. Bok JW, et al. 2009. Chromatin-level regulation of biosynthetic gene clusters. Nat. Chem. Biol. 5:462–464 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 12. Bok JW, et al. 2006. Genomic mining for Aspergillus natural products. Chem. Biol. 13:31–37 [DOI] [PubMed] [Google Scholar]
 - 13. Brakhage A, Schroeckh V. 2011. Fungal secondary metabolites—strategies to activate silent gene clusters. Fungal Genet. Biol. 48:15–22 [DOI] [PubMed] [Google Scholar]
 - 14. Brakhage AA, et al. 2008. Activation of fungal silent gene clusters: a new avenue to drug discovery. Prog. Drug Res. 66:1, 3-12 [DOI] [PubMed] [Google Scholar]
 - 15. Braus GH, Irniger S, Bayram O. 2010. Fungal development and the COP9 signalosome. Curr. Opin. Microbiol. 13:672–676 [DOI] [PubMed] [Google Scholar]
 - 16. Brodhagen M, Keller NP. 2006. Signalling pathways connecting mycotoxin production and sporulation. Mol. Plant Pathol. 7:285–301 [DOI] [PubMed] [Google Scholar]
 - 17. Busch S, Eckert SE, Krappmann S, Braus GH. 2003. The COP9 signalosome is an essential regulator of development in the filamentous fungus Aspergillus nidulans. Mol. Microbiol. 49:717–730 [DOI] [PubMed] [Google Scholar]
 - 18. Busch S, et al. 2007. An eight-subunit COP9 signalosome with an intact JAMM motif is required for fungal fruit body formation. Proc. Natl. Acad. Sci. U. S. A. 104:8089–8094 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 19. Chiang YM, Chang SL, Oakley BR, Wang CC. 2011. Recent advances in awakening silent biosynthetic gene clusters and linking orphan clusters to natural products in microorganisms. Curr. Opin. Chem. Biol. 15:137–143 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 20. Chiang YM, et al. 2009. A gene cluster containing two fungal polyketide synthases encodes the biosynthetic pathway for a polyketide, asperfuranone, in Aspergillus nidulans. J. Am. Chem. Soc. 131:2965–2970 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 21. Clutterbuck AJ. 1974. Aspergillus nidulans, p 447–510 In King RC. (ed), Handbook of genetics. Plenum Press, New York, NY [Google Scholar]
 - 22. Cooper MA, Shlaes D. 2011. Fix the antibiotics pipeline. Nature 472:32 doi:10.1038/472032a [DOI] [PubMed] [Google Scholar]
 - 23. Dong J, et al. 2006. New nematicidal azaphilones from the aquatic fungus Pseudohalonectria adversaria YMF1.01019. FEMS Microbiol. Lett. 264:65–69 [DOI] [PubMed] [Google Scholar]
 - 24. Eckert SE, Kubler E, Hoffmann B, Braus GH. 2000. The tryptophan synthase-encoding trpB gene of Aspergillus nidulans is regulated by the cross-pathway control system. Mol. Gen. Genet. 263:867–876 [DOI] [PubMed] [Google Scholar]
 - 25. Esser K. 1982. Cryptogams: cyanobacteria, algae, fungi, lichens. Textbook and practical guide. Cambridge University Press, Cambridge, United Kingdom [Google Scholar]
 - 26. Fisch KM, et al. 2009. Chemical induction of silent biosynthetic pathway transcription in Aspergillus niger. J. Ind. Microbiol. 36:1199–1213 [DOI] [PubMed] [Google Scholar]
 - 27. Frisvad JC, et al. 2007. Secondary metabolite profiling, growth profiles and other tools for species recognition and important Aspergillus mycotoxins. Stud. Mycol. 59:31–37 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 28. Garcia-Estrada C, et al. 2011. A single cluster of coregulated genes encodes the biosynthesis of the mycotoxins roquefortine C and meleagrin in Penicillium chrysogenum. Chem. Biol. 18:1499–1512 [DOI] [PubMed] [Google Scholar]
 - 29. Grant CE, Bailey TL, Noble WS. 2011. FIMO: scanning for occurrences of a given motif. Bioinformatics 27:1017–1018 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 30. Gross H. 2009. Genomic mining—a concept for the discovery of new bioactive natural products. Curr. Opin. Drug Discov. Devel. 12:207–219 [PubMed] [Google Scholar]
 - 31. Gupta S, Stamatoyannopoulos JA, Bailey TL, Noble WS. 2007. Quantifying similarity between motifs. Genome Biol. 8:R24 doi:10.1186/gb-2007-8-2-r24 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 32. Hanahan D, Jessee J, Bloom FR. 1991. Plasmid transformation of Escherichia coli and other bacteria. Methods Enzymol. 204:63–113 [DOI] [PubMed] [Google Scholar]
 - 33. Hawksworth DL, Rossman AY. 1997. Where are all the undescribed fungi? Phytopathology 87:888–891 [DOI] [PubMed] [Google Scholar]
 - 34. Henrikson JC, Hoover AR, Joyner PM, Cichewicz RH. 2009. A chemical epigenetics approach for engineering the in situ biosynthesis of a cryptic natural product from Aspergillus niger. Org. Biomol. Chem. 7:435–438 [DOI] [PubMed] [Google Scholar]
 - 35. Hertweck C. 2009. Hidden biosynthetic treasures brought to light. Nat. Chem. Biol. 5:450–452 [DOI] [PubMed] [Google Scholar]
 - 36. Hosaka T, et al. 2009. Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12. Nat. Biotechnol. 27:462–464 [DOI] [PubMed] [Google Scholar]
 - 37. Keller M, Zengler K. 2004. Tapping into microbial diversity. Nat. Rev. Microbiol. 2:141–150 [DOI] [PubMed] [Google Scholar]
 - 38. Keller NP, Turner G, Bennett JW. 2005. Fungal secondary metabolism—from biochemistry to genomics. Nat. Rev. Microbiol. 3:937–947 [DOI] [PubMed] [Google Scholar]
 - 39. Lingens F, Göbel W. 1967. Zur Biosynthese des Tryptophans in Saccharomyces cerevisiae. Biochim. Biophys. Acta 148:70–83 [PubMed] [Google Scholar]
 - 40. Liu T, Chiang YM, Somoza AD, Oakley BR, Wang CC. 2011. Engineering of an “unnatural” natural product by swapping polyketide synthase domains in Aspergillus nidulans. J. Am. Chem. Soc. 133:13314–13316 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 41. Mapari SA, Thrane U, Meyer AS. 2010. Fungal polyketide azaphilone pigments as future natural food colorants? Trends Biotechnol. 28:300–307 [DOI] [PubMed] [Google Scholar]
 - 42. Meinicke P, et al. 2008. Metabolite-based clustering and visualization of mass spectrometry data using one-dimensional self-organizing maps. Algorithms Mol. Biol. 3:9 doi:10.1186/1748-7188-3-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 43. Mitova MI, et al. 2006. Chrysosporide, a cyclic pentapeptide from a New Zealand sample of the fungus Sepedonium chrysospermum. J. Nat. Prod. 69:1481–1484 [DOI] [PubMed] [Google Scholar]
 - 44. Mota-Meira M, LaPointe G, Lacroix C, Lavoie MC. 2000. MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens. Antimicrob. Agents Chemother. 44:24–29 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 45. Nahlik K, et al. 2010. The COP9 signalosome mediates transcriptional and metabolic response to hormones, oxidative stress protection and cell wall rearrangement during fungal development. Mol. Microbiol. 78:964–979 [DOI] [PubMed] [Google Scholar]
 - 46. Nielsen ML, et al. 2011. A genome-wide polyketide synthase deletion library uncovers novel genetic links to polyketides and meroterpenoids in Aspergillus nidulans. FEMS Microbiol. Lett. 321:157–166 [DOI] [PubMed] [Google Scholar]
 - 47. Nowrousian M. 2009. A novel polyketide biosynthesis gene cluster is involved in fruiting body morphogenesis in the filamentous fungi Sordaria macrospora and Neurospora crassa. Curr. Genet. 55:185–198 [DOI] [PubMed] [Google Scholar]
 - 48. Nutzmann HW, et al. 2011. Bacteria-induced natural product formation in the fungus Aspergillus nidulans requires Saga/Ada-mediated histone acetylation. Proc. Natl. Acad. Sci. U. S. A. 108:14282–14287 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 49. Ochi K, et al. 2004. Ribosome engineering and secondary metabolite production. Adv. Appl. Microbiol. 56:155–184 [DOI] [PubMed] [Google Scholar]
 - 50. Osmanova N, Schultze W, Ayoub N. 2010. Azaphilones: a class of fungal metabolites with diverse biological activities. Phytochem. Rev. 9:315–342 [Google Scholar]
 - 51. Phonkerd N, et al. 2008. Bis-spiro-azaphilones and azaphilones from the fungi Chaetomium cochliodes VTh01 and C. cochliodes CTh05. Tetrahedron 64:9636–9645 [Google Scholar]
 - 52. Porter JK, Bacon CW, Robbins JD, Himmelsbach DS, Higman HC. 1977. Indole alkaloids from Balansia epichloe (Weese). J. Agric. Food Chem. 25:88–93 [DOI] [PubMed] [Google Scholar]
 - 53. Sakai K, Kinoshita H, Shimizu T, Nihira T. 2008. Construction of a citrinin gene cluster expression system in heterologous Aspergillus oryzae. J. Biosci. Bioeng. 106:466–472 [DOI] [PubMed] [Google Scholar]
 - 54. Sanchez JF, et al. 2010. Molecular genetic analysis of the orsellinic acid/F9775 gene cluster of Aspergillus nidulans. Mol. Biosyst. 6:587–593 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 55. Sarikaya Bayram O, et al. 2010. LaeA control of velvet family regulatory proteins for light-dependent development and fungal cell-type specificity. PLoS Genet. 6:e1001226 doi:10.1371/journal.pgen.1001226 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 56. Scherlach K, Hertweck C. 2009. Triggering cryptic natural product biosynthesis in microorganisms. Org. Biomol. Chem. 7:1753–1760 [DOI] [PubMed] [Google Scholar]
 - 57. Scherlach K, et al. 2011. Cytotoxic pheofungins from an engineered fungus impaired in posttranslational protein modification. Angew. Chem. Int. Ed. Engl. 50:9843–9847 [DOI] [PubMed] [Google Scholar]
 - 58. Schroeckh V, et al. 2009. Intimate bacterial-fungal interaction triggers biosynthesis of archetypal polyketides in Aspergillus nidulans. Proc. Natl. Acad. Sci. U. S. A. 106:14558–14563 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 59. Shaaban MI, Bok JW, Lauer C, Keller NP. 2010. Suppressor mutagenesis identifies a velvet complex remediator of Aspergillus nidulans secondary metabolism. Eukaryot. Cell 9:1816–1824 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 60. Shao CL, et al. 2011. Aspergilones A and B, two benzylazaphilones with an unprecedented carbon skeleton from the gorgonian-derived fungus Aspergillus sp. Bioorg. Med. Chem. Lett. 21:690–693 [DOI] [PubMed] [Google Scholar]
 - 61. Shwab EK, et al. 2007. Histone deacetylase activity regulates chemical diversity in Aspergillus. Eukaryot. Cell 6:1656–1664 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 62. Somoza AD, Lee KH, Chiang YM, Oakley BR, Wang CC. 2012. Reengineering an azaphilone biosynthesis pathway in Aspergillus nidulans to create lipoxygenase inhibitors. Org. Lett. 14:972–975 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 63. Suzuki T, et al. 2001. Synthesis of 7-acetyloxy-3,7-dimethyl-7,8-dihydro-6H-isochromene-6,8-dione and its analogues. J. Heterocycl. Chem. 38:1409–1418 [Google Scholar]
 - 64. Szewczyk E, et al. 2008. Identification and characterization of the asperthecin gene cluster of Aspergillus nidulans. Appl. Environ. Microbiol. 74:7607–7612 [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 65. Vogel HJ. 1956. A convenient growth medium for Neurospora. Microb. Genet. Bull. 13:42–43 [Google Scholar]
 - 66. von Dohren H. 2009. A survey of nonribosomal peptide synthetase (NRPS) genes in Aspergillus nidulans. Fungal Genet. Biol. 46(Suppl 1):S45–S52 doi:10.1016/j.fgb.2008.08.008 [DOI] [PubMed] [Google Scholar]
 - 67. Wagner-Dobler I, et al. 2004. Oceanibulbus indolifex gen. nov., sp. nov., a North Sea alphaproteobacterium that produces bioactive metabolites. Int. J. Syst. Evol. Microbiol. 54:1177–1184 [DOI] [PubMed] [Google Scholar]
 - 68. Wei N, Chamovitz DA, Deng XW. 1994. Arabidopsis COP9 is a component of a novel signaling complex mediating light control of development. Cell 78:117–124 [DOI] [PubMed] [Google Scholar]
 - 69. Wei N, Serino G, Deng XW. 2008. The COP9 signalosome: more than a protease. Trends Biochem. Sci. 33:592–600 [DOI] [PubMed] [Google Scholar]
 - 70. Williams RB, Henrikson JC, Hoover AR, Lee AE, Cichewicz RH. 2008. Epigenetic remodeling of the fungal secondary metabolome. Org. Biomol. Chem. 6:1895–1897 [DOI] [PubMed] [Google Scholar]
 - 71. Wu JT, Lin HC, Hu YC, Chien CT. 2005. Neddylation and deneddylation regulate Cul1 and Cul3 protein accumulation. Nat. Cell Biol. 7:1014–1020 [DOI] [PubMed] [Google Scholar]
 - 72. Yang SW, et al. 2009. Sch 1385568, a new azaphilone from Aspergillus sp. J. Antibiot. 62:401–403 [DOI] [PubMed] [Google Scholar]
 - 73. Yasukawa K, et al. 1994. Azaphilones inhibit tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mice. Oncology 51:108–112 [DOI] [PubMed] [Google Scholar]
 - 74. Yu JH, Keller N. 2005. Regulation of secondary metabolism in filamentous fungi. Annu. Rev. Phytopathol. 43:437–458 [DOI] [PubMed] [Google Scholar]
 - 75. Zähner H, Drautz H, Weber W. 1982. Novel approaches to metabolite screening, p 51–70 In Bu'lock JD, Nisbet LJ, Winstanley DJ. (ed), Bioactive microbial products: search and discovery. Academic Press, New York, NY [Google Scholar]
 - 76. Zerikly M, Challis GL. 2009. Strategies for the discovery of new natural products by genome mining. Chembiochem 10:625–633 [DOI] [PubMed] [Google Scholar]
 - 77. Zhang H, Boghigian BA, Armando J, Pfeifer BA. 2011. Methods and options for the heterologous production of complex natural products. Nat. Prod. Rep. 28:125–151 [DOI] [PMC free article] [PubMed] [Google Scholar]
 
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



